IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
EP Biocomposites IPO is a Fixed Price listing on BSE SME exchange. The company is based in Goa and caters to Plastic And Polymer sector. Aryaman Financial Services is the merchant banker of EP Biocomposites IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 1st February 2022.
EP Biocomposites IPO posted revenues of ₹ 8.08 crores and PAT of ₹ 0.81 crores in FY00 on annualised basis.
Revenue:
₹ 8.06 Cr.
EBITDA Margin:
14.52
% 
Net Worth: ₹ 1.99 Cr.
Market Capitalisation:
₹ 21.19 Cr.
P/E:
26.20 times
P/BV: 2.54 times
EV/EBITDA: 21.50 times
Financial results of EP Biocomposites IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY22 | FY21 | FY20 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 9.28 | 1.32 | 0.55 | ||
| Net Worth | 1.99 | 0.39 | -0.02 | ||
| Total Debt | 4.12 | [●] | [●] | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
8.06 | 2.95 | 0.57 | ||
EBITDA
EBITDA on annualised basis |
1.17 | 0.46 | 0.04 | ||
PAT
PAT on annualised basis |
0.81 | 0.35 | 0.03 | ||
EP Biocomposites IPO PAT Margin is 10.05 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows EP Biocomposites IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY22 | FY21 | FY20 |
|---|---|---|---|
| EBITDA Margin (%) | 14.52 | 15.59 | 7.02 |
| PAT Margin (%) | 10.05 | 11.86 | 5.26 |
| EPS (₹) | 9.48 | 6.97 | 0.61 |
| ROE (%) | 40.70 | 89.74 | -150.00 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 8.73 | 26.52 | 5.45 |
| Debt to Equity | 2.07 | [●] | [●] |
The market Capitalisation of EP Biocomposites IPO is ₹ 21.19 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The EP Biocomposites IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows EP Biocomposites IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of EP Biocomposites IPO is ₹ 21.19 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The EP Biocomposites IPO has a Price-to-Earnings (PE) ratio of 26.20 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
EP Biocomposites IPO reported revenue of ₹ 8.08 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from EP Biocomposites IPO provide insights into sales growth, market demand, and business scalability.
EP Biocomposites recorded an EBITDA of ₹ 1.17 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
EP Biocomposites Profit After Tax (PAT) is ₹ 0.81 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 8.06 Cr.
EBITDA Margin:
14.52
%
Net Worth: ₹ 1.99 Cr.
Market Capitalisation:
₹ 21.19 Cr.
P/E:
26.20 times
P/BV: 2.54 times
EV/EBITDA: 21.50 times
EP Biocomposites operates in Plastic And Polymer and Manufacturing And Supply Of Fibre Re-inforced Polymers. The Issue is listed on BSE SME in Sep, 2022. EP Biocomposites IPO size was 6.35 with Issue price of 126.00 .
Merchant Banker(s) of EP Biocomposites IPO: Aryaman Financial Services Limited
EP Biocomposites IPO subscription was 18.51 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
EP Biocomposites IPO listed at a listing price of 168.25 against the offer price of 126.00.
The current market price of EP Biocomposites is 127.95.
Why Us?
